ABBV Debt-to-Equity Ratio Analysis

The Debt-to-Equity Ratio compares a company’s total debt to its shareholders’ equity; AbbVie’s current 2.65x means it carries $2.65 in debt for every $1 of equity.

This is far above the healthcare sector median of 0.47x and places AbbVie in the 94th percentile among its peers, indicating much higher leverage than most. Over the last eight quarters the ratio has been trending upward, yet the year-over-year and quarter-over-quarter changes are both exactly +0.0%, meaning the ratio has been flat at 2.65x for some time after earlier periods when it was deeply negative (-21.06x). The combination of a very high ratio with a stable trend implies that while the company remains highly leveraged relative to the industry, it is not adding further debt, and the extreme negative-equity phase has passed. This elevated leverage introduces financial risk, as a high debt load can strain cash flows if earnings weaken. However, the flat trend and the overall NEUTRAL verdict are consistent: the metric signals above-average risk, but other factors likely offset it, preventing a bearish or bullish call.

Frequently Asked Questions

Closest Sector Peers